Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;37(12):e1388-e1389.
doi: 10.1111/jdv.19334. Epub 2023 Jul 26.

Regarding Mastorino et al.'s 'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'

Sebastian Yu  1   2 , James Cheng-Chung Wei  3   4   5
Affiliations
Comment

Regarding Mastorino et al.'s 'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'

Sebastian Yu et al. J Eur Acad Dermatol Venereol. 2023 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Mastorino L, Susca S, Cariti C, Sliquini N, Verrone A, Stroppiana E, et al. Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients. J Eur Acad Dermatol Venereol. 2023;37:1848-1853.
    1. Reich K, Armstrong AW, Langley RG, Flavin S, Randazzo B, Li S, et al. Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial. Lancet. 2019;394:831-839.
    1. Armstrong AW, Soliman AM, Betts KA, Wang Y, Gao Y, Stakias V, et al. Long-term benefit-risk profiles of treatments for moderate-to-severe plaque psoriasis: a network meta-analysis. Dermatol Ther (Heidelb). 2022;12:167-184.
    1. Yang SF, Chen TH, Tsai SH, Chen PE, Chi CC, Tung TH. Risk of chronic kidney disease and end-stage renal disease in patients with psoriasis: a systematic review and meta-analysis of cohort studies. Dermatol Sin. 2021;39:19-26.
    1. Lai TL, Au CK, Chung HY, Lau CS. Depression in psoriatic arthritis: related to socio-demographics, comorbid loads or disease activity? Int J Rheum Dis. 2022;25:474-480.

MeSH terms

LinkOut - more resources